Foghorn Therapeutics Inc. Profile Avatar - Palmy Investing

Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform t…

Biotechnology
US, Cambridge [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Foghorn Therapeutics Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Foghorn Therapeutics Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Foghorn Therapeutics Inc..

End of FHTX's Analysis
CIK: 1822462 CUSIP: 344174107 ISIN: US3441741077 LEI: - UEI: -
Secondary Listings
FHTX has no secondary listings inside our databases.